Stem Cell and Gene Therapy for Cardiovascular Disease
- Publisher's listprice EUR 108.00
-
44 793 Ft (42 660 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 8 959 Ft off)
- Discounted price 35 834 Ft (34 128 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
44 793 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier Science
- Date of Publication 26 August 2015
- ISBN 9780128018880
- Binding Paperback
- No. of pages538 pages
- Size 276x215 mm
- Weight 1430 g
- Language English 0
Categories
Long description:
Stem Cell and Gene Therapy for Cardiovascular Disease is a state-of-the-art reference that combines, in one place, the breadth and depth of information available on the topic.
As stem cell and gene therapies are the most cutting-edge therapies currently available for patients with heart failure, each section of the book provides information on medical trials from contributors and specialists from around the world, including not only what has been completed, but also what is planned for future research and trials.
Cardiology researchers, basic science clinicians, fellows, residents, students, and industry professionals will find this book an invaluable resource for further study on the topic.
MoreTable of Contents:
1. Introduction and Overview of Stem Cells
2. Mechanistic Insights from Pathologic Perspective
3. Large Animal Models to Study Stem Cell Therapy
4. Evolution of understanding of the mechanisms of repair
5. Impact of Age on Stem Cell Function
6. Bone Marrow Mononuclear Cells
7. Chronic Limb Ischemia
8. Chronic/Refractory Angina
9. Acute Myocardial Infarction
A. European Experience
B. US Experience
10. Chronic Ischemic Heart Failure
11. Adipose Tissue
12. Overview of MSCsï¿1⁄2ï¿1⁄2ï¿1⁄2ï¿1⁄2ï¿1⁄2
13. Allogeneic vs Autologous Source: Comparative Effects
14. Use of MSCs for AMI
15. Combined Cell Strategies
16. Heart Failure
17. C-Kit+ cells
18. Cardiospheres
19. Umbilical Cord, Placenta, Endometrium
20. Genetic Engineering of Fibroblasts to Cardiomyocytes
21. Transformation to inducible Pleuripotent Stem Cells
22. Transformation to MAPC's
23. Transcoronary and Endocardial
24. Retrograde and Epicardial
25. Epicardial Patch
26. Matrix Scaffolds
27. Matrix plus cellsï¿1⁄2
28. Biomaterial: Alginate
29. Organogenesis
30. Pre-clinical Identification of target genes
31. SERCA-2a gene for recovery of inotropic function
32. SDF-1 Gene for Heart Failure Non-Inotropic Mechanisms
33. Gene Therapy for Angiogenesis: Chronic Limb Ischemiaï¿1⁄2
34. Stem Cells Target Gene Transfected Stem Cells
35. CCTRN: Past, Present, and Vision for the Future
36. Signature of Responders-lessons from Bio-Repository
37. Adjunctive therapy with LVADs for Recovery
38. Trials in Non-Ischemic Heart Failure
39. Enhancing Stem Cell Homing for Tissue Repair
40. Stroke: Pre-Clinical and Clinical Trial Data
